A new trading day began on Monday, with Immunic Inc (NASDAQ: IMUX) stock price up 7.00% from the previous day of trading, before settling in for the closing price of $1.00. IMUX’s price has ranged from $0.97 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 54.30%. With a float of $87.36 million, this company’s outstanding shares have now reached $90.08 million.
Let’s determine the extent of company efficiency that accounts for 77 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 3.02%, while institutional ownership is 62.53%. The most recent insider transaction that took place on Nov 12 ’24, was worth 100,369. In this transaction Director of this company bought 87,300 shares at a rate of $1.15, taking the stock ownership to the 87,300 shares.
Immunic Inc (IMUX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.50% during the next five years compared to 31.12% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Here are Immunic Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Looking closely at Immunic Inc (NASDAQ: IMUX), its last 5-days average volume was 1.04 million, which is a jump from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 11.67%. Additionally, its Average True Range was 0.09.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 6.31%, which indicates a significant decrease from 20.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.35% in the past 14 days, which was lower than the 76.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2339, while its 200-day Moving Average is $1.3171. However, in the short run, Immunic Inc’s stock first resistance to watch stands at $1.0983. Second resistance stands at $1.1267. The third major resistance level sits at $1.1633. If the price goes on to break the first support level at $1.0333, it is likely to go to the next support level at $0.9967. Should the price break the second support level, the third support level stands at $0.9683.
Immunic Inc (NASDAQ: IMUX) Key Stats
With a market capitalization of 96.38 million, the company has a total of 90,079K Shares Outstanding. Currently, annual sales are 0 K while annual income is -93,610 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,370 K.
